Relay Therapeutics, Inc. (RLAY) Insider Trading

Over the last 3 months, RLAY insiders made 0 open-market buys and 7 sales, a net sale of -$711K (SEC Form 4). Over the last 6 months, 180 institutions increased and 109 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
7
Net (3m)
-$711.1K
Insider trades by month Buys Sells
Oct
Nov
Jan
Mar
Apr
May
Context3-month price +50.7%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
May 14, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell17,717$12.86
Apr 30, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell972$14.79
Apr 30, 2026Rahmer Peterofficer: See remarksSell753$14.79
Apr 30, 2026Bergstrom Donald Aofficer: President, R&DSell1,490$14.79
Apr 9, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell1,800$15.00
Apr 9, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell17,717$13.01
Apr 9, 2026Catinazzo Thomasofficer: Chief Financial OfficerOption1,800$5.22
Mar 11, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell17,717$10.06
Jan 29, 2026Rahmer Peterofficer: See remarksGrant994$2.99
Jan 29, 2026Bergstrom Donald Aofficer: President, R&DSell18,895$7.62
Jan 29, 2026Rahmer Peterofficer: See remarksSell11,684$7.62
Jan 29, 2026Rahmer Peterofficer: See remarksSell1,354$8.45
Jan 29, 2026Bergstrom Donald Aofficer: President, R&DSell2,686$8.45
Jan 29, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell13,820$7.62
Jan 29, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell1,695$8.45
Jan 15, 2026Bergstrom Donald Aofficer: President, R&DGrant575,000$7.94
Jan 15, 2026Rahmer Peterofficer: See remarksGrant475,000$7.94
Jan 15, 2026Patel Sanjivdirector, officer: President and CEOGrant1,450,000$7.94
Jan 15, 2026Catinazzo Thomasofficer: Chief Financial OfficerGrant400,000$7.94
Jan 7, 2026Patel Sanjivdirector, officer: President and CEOGrant994$2.99
Jan 7, 2026Patel Sanjivdirector, officer: President and CEOSell43,168$7.82
Nov 6, 2025COATS LONNELdirectorGrant207,931$6.86
Nov 6, 2025Dable Habib JdirectorGrant207,931$6.86
Nov 4, 2025Patel Sanjivdirector, officer: President and CEOSell62,073$7.00
Oct 30, 2025Bergstrom Donald Aofficer: President, R&DSell30,897$7.29
Oct 30, 2025Catinazzo Thomasofficer: Chief Financial OfficerSell21,664$7.29
Oct 30, 2025Rahmer Peterofficer: See remarksSell21,394$7.50
Oct 30, 2025Rahmer Peterofficer: See remarksSell19,135$7.29
Jul 30, 2025Rahmer Peterofficer: See remarksSell15,724$3.68
Jul 30, 2025Catinazzo Thomasofficer: Chief Financial OfficerSell1,701$3.74

Source: RLAY SEC Form 4 filings, latest May 14, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their RLAY positions over the last 6 months (SEC Form 13F).

Increased
180
New positions
88
Reduced
109
Sold out
52
Largest moves
InstitutionActionSharesFiled
SB INVESTMENT ADVISERS (UK) LTDUnchanged27.9MMay 18, 2026
SB INVESTMENT ADVISERS (UK) LTDUnchanged27.9MFeb 18, 2026
PERCEPTIVE ADVISORS LLCIncreased19.5MMay 29, 2026
COMMODORE CAPITAL LPUnchanged17.0MFeb 17, 2026
COMMODORE CAPITAL LPUnchanged17.0MMay 15, 2026
CASDIN CAPITAL, LLCIncreased14.4MMay 15, 2026
POINT72 ASSET MANAGEMENT, L.P.Reduced13.9MFeb 17, 2026
BLACKROCK, INC.Reduced13.2MFeb 12, 2026
CASDIN CAPITAL, LLCIncreased13.0MFeb 17, 2026
BLACKROCK, INC.Reduced13.0MMay 13, 2026
VANGUARD GROUP INCIncreased9.7MJan 29, 2026
BELLEVUE GROUP AGReduced8.3MFeb 17, 2026
BELLEVUE GROUP AGReduced7.8MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position7.4MMay 15, 2026
STATE STREET CORPIncreased6.4MFeb 13, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.